ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,325, issued on April 7, was assigned to Yale University (New Haven, Conn.). "Interleukin-18 variants and methods of use" was invented by Aa... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,326, issued on April 7, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark). "Compositions of GLP-1 peptides and preparation thereof" was... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,327, issued on April 7, was assigned to The Trustees of the University of Pennylvania (Philadelphia). "Compositions useful for treating GM1... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,328, issued on April 7, was assigned to Intervet Inc. (Rahway, N.J.). "Combination of vaccines to prophylactically treat a pig" was invente... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,329, issued on April 7, was assigned to University of Denver (Denver). "Virus-like particles" was invented by Schuyler B. van Engelenburg (... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,330, issued on April 7, was assigned to Regents of the University of Minnesota (Minneapolis) and HENNEPIN HEALTHCARE RESEARCH INSTITUTE (Min... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,331, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "Methods of treating psoriasis with secukinumab" was invented by ... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,332, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "Methods of treating psoriasis with secukinumab" was invented by ... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,333, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "Methods of treating inflammatory arthritis using IL-17 antagonis... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,334, issued on April 7, was assigned to Gmax Biopharm LLC (Hangzhou, China). "ET a R antibody, and pharmaceutical compositions and use ther... Read More